Nebulised Heparin in Patients With COVID-19 Pneumonia

Clinical trial NCT05255848 · UNKNOWN

Trial details

NCT number: NCT05255848
Sponsor: Lady Reading Hospital, Pakistan
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2022-06-20
Primary completion: 2022-08-20
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.